EP Patent

EP3366680A1 — Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases

Assigned to Parion Sciences Inc · Expires 2018-08-29 · 8y expired

What this patent protects

Sodium channel blockers represented by the formula are provided. The invention also includes a variety of compositions, combinations and these inventive sodium channel blockers for use as a medicament.

USPTO Abstract

Sodium channel blockers represented by the formula are provided. The invention also includes a variety of compositions, combinations and these inventive sodium channel blockers for use as a medicament.

Drugs covered by this patent

Patent Metadata

Patent number
EP3366680A1
Jurisdiction
EP
Classification
Expires
2018-08-29
Drug substance claim
No
Drug product claim
No
Assignee
Parion Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.